Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test.

Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER.

Curr Drug Saf. 2006 Jan;1(1):63-71.

PMID:
18690916
2.

Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.

Roth T, Eklov SD, Drake CL, Verster JC.

Traffic Inj Prev. 2014;15(5):439-45. doi: 10.1080/15389588.2013.830211. Review.

PMID:
24678565
3.

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.

Verster JC, Volkerts ER, Schreuder AH, Eijken EJ, van Heuckelum JH, Veldhuijzen DS, Verbaten MN, Paty I, Darwish M, Danjou P, Patat A.

J Clin Psychopharmacol. 2002 Dec;22(6):576-83.

PMID:
12454557
4.

Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability.

Verster JC, van de Loo AJ, Moline ML, Roth T.

Curr Drug Saf. 2014;9(3):205-11. Review.

PMID:
24909576
5.

Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.

Vermeeren A, Vuurman EF, Leufkens TR, Van Leeuwen CJ, Van Oers AC, Laska E, Rico S, Steinberg F, Roth T.

Sleep. 2014 Mar 1;37(3):489-96. doi: 10.5665/sleep.3482.

6.

Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.

Mets MA, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, Verster JC.

Sleep. 2011 Oct 1;34(10):1327-34. doi: 10.5665/SLEEP.1272.

7.

Residual effects of sleep medication on driving ability.

Verster JC, Veldhuijzen DS, Volkerts ER.

Sleep Med Rev. 2004 Aug;8(4):309-25. Review.

PMID:
15233958
8.

Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.

Verster JC, Spence DW, Shahid A, Pandi-Perumal SR, Roth T.

Curr Drug Saf. 2011 Sep 1;6(4):209-18. Review.

PMID:
22129315
9.

Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.

Leufkens TR, Vermeeren A.

Clin Ther. 2014 Jan 1;36(1):141-50. doi: 10.1016/j.clinthera.2013.11.005. Epub 2013 Dec 17.

10.

On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.

Vermeeren A, Vets E, Vuurman EF, Van Oers AC, Jongen S, Laethem T, Heirman I, Bautmans A, Palcza J, Li X, Troyer MD, Wrishko R, McCrea J, Sun H.

Psychopharmacology (Berl). 2016 Sep;233(18):3341-51. doi: 10.1007/s00213-016-4375-x. Epub 2016 Jul 16.

11.

Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.

Leufkens TR, Vermeeren A.

J Clin Psychopharmacol. 2009 Oct;29(5):432-8. doi: 10.1097/JCP.0b013e3181b57b43.

PMID:
19745642
12.

Zolpidem and traffic safety - the importance of treatment compliance.

Verster JC, Volkerts ER, Olivier B, Johnson W, Liddicoat L.

Curr Drug Saf. 2007 Sep;2(3):220-6. Review.

PMID:
18690971
13.

Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.

Leufkens TR, Lund JS, Vermeeren A.

J Sleep Res. 2009 Dec;18(4):387-96. doi: 10.1111/j.1365-2869.2009.00746.x. Epub 2009 Jun 22.

14.

Lapses of attention as outcome measure of the on-the-road driving test.

Verster JC, Bervoets AC, de Klerk S, Roth T.

Psychopharmacology (Berl). 2014 Jan;231(1):283-92. doi: 10.1007/s00213-013-3236-0. Epub 2013 Aug 24.

PMID:
23975036
15.

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.

Ramaekers JG, Conen S, de Kam PJ, Braat S, Peeters P, Theunissen EL, Ivgy-May N.

Psychopharmacology (Berl). 2011 May;215(2):321-32. doi: 10.1007/s00213-010-2149-4. Epub 2011 Jan 19.

16.

Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.

Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A.

Sleep. 2002 Mar 15;25(2):224-31.

PMID:
11905433
17.

On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.

Vermeeren A, Sun H, Vuurman EF, Jongen S, Van Leeuwen CJ, Van Oers AC, Palcza J, Li X, Laethem T, Heirman I, Bautmans A, Troyer MD, Wrishko R, McCrea J.

Sleep. 2015 Nov 1;38(11):1803-13. doi: 10.5665/sleep.5168.

18.

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.

Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L.

Hum Psychopharmacol. 2008 Dec;23(8):693-705. doi: 10.1002/hup.980.

PMID:
18763235
19.

Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia.

Partinen M, Hirvonen K, Hublin C, Halavaara M, Hiltunen H.

Sleep Med. 2003 Nov;4(6):553-61.

PMID:
14607350
20.

Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Ramaekers JG.

J Clin Psychiatry. 2003 Jan;64(1):20-9. Review.

PMID:
12590619

Supplemental Content

Support Center